Address
3 More London Riverside
London, SE1 2AQ
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 11 7284 2535
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1210
First IPO Date
March 19, 2021
| Name | Title | Pay | Year Born |
| Veronique Ameye | Chief Executive Officer & General Counsel | 0 | 1977 |
| Giffin Daughtridge | President of North America Commercial Operations & Global Molecular Solutions | 0 | N/A |
| Melissa Garcia | Vice President & Corporate Counsel | 0 | N/A |
LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of tests that deliver laboratory-grade performance directly at the point of care. With approximately 30 tests either commercially available or under development, their comprehensive portfolio addresses critical conditions such as infectious diseases, cardiovascular disorders, diabetes, and coagulation issues. Furthermore, they offer a full suite of COVID-19 testing solutions, adaptable for both laboratory environments and immediate point-of-need applications. These diagnostic tools are widely adopted by governments and healthcare institutions, deployed in diverse settings including traditional laboratories, urgent care clinics, physician's offices, pharmacies, schools, and workplaces. Their applications span screening, diagnosis, and monitoring for both general wellness and specific diseases. Established in 2014, the company's headquarters are located in London, United Kingdom.